Purpose Statement

The purpose of this activity is to educate participants on the current status of antiviral therapy developments for chronic hepatitis B and C. Current and new therapeutic targets will be reviewed, as well as the most recent clinical data with new therapeutic approaches and the issue of viral resistance to antiviral drugs. As antiviral therapy has become increasingly effective it is important to understand how improving clinical response has or should affect the therapeutic indications for chronic hepatitis.

Target Audience

Hepatologists, Gastroenterologists, ID specialists, Laboratory Professionals (directors and medical technologists) working in the areas of Viral Hepatitis in hospital institutions, reference laboratories, and public health departments.

Learning Objectives

After completing this activity, the participant should be able to:

1.     Describe the role of viral replication in disease progression of HBV or HCV.

2.     Identify patients with active viral replication who are candidates for antiviral therapy.

3.     Explain the most recent data on HCV drugs in clinical development.

4.     Recognize the emergence of antiviral resistance in treatment of chronic viral hepatitis.

Faculty

Professor Jean-Michel Pawlotsky, MD, PhD

Director, National Reference Center for Viral Hepatitis B, C and delta

Department of Virology & INSERM U955

Henri Mondor Hospital, University of Paris 12

Paul Martin, MD., FACP

Professor of Medicine

Chief, Division of Hepatology

University of Miami

Educational Activity Agenda

- 02 minutes: Welcome & Introduction
- 50 minutes: Faculty Presentations
- 15 minutes: Q&A Session
- 08 minutes: Conclusion, Evaluation & Post-Test

Disclosure of Conflicts of Interest

Global Education Group adheres to the ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships as well as the discussion of unlabeled/investigational use of any drug, device or procedure by the faculty, are made known below.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME and P.A.C.E.^® accredited activity:

Faculty Disclosure of Unlabeled Use / Investigational Use

In this activity, the following faculty discloses that they may discuss the unlabeled or investigational use of drugs, devices or procedures in their discussions regarding hepatitis therapy:

• Jean-Michel Pawlotsky, MD, PhD
• Paul Martin, MD

Planners and Managers

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse / life partner have with commercial interests related to the content of this CME accredited activity:

CME (ACCME) Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group and Dane Garvin Ltd. Global Education Group is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation - Physician, CME

Global Education Group designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For any questions concerning the accreditation of this activity, please contact Global Education Group at (303) 395-1782, or inquire@globaleducationgroup.com.

How to Obtain CME Credit

ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED

Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit(s)™. To receive credit, the course must be completed before July 1, 2011.

Participants who have already received continuing education credit for attending the May 19th, 2010 live webcast are not eligible to receive additional credit for this enduring online activity.

Participation in this activity should be completed in approximately 1.25 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

• Read all of the CME accreditation information above.
• View the complete webcast program.
• Click on the link to apply for CME credits.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME certificate for participation in this activity. 

Should you have any CME questions regarding this activity, please contact:

Global Education Group
5575 S. Sycamore Street, Suite 200
Littleton, CO 80120
Phone: 303-395-1782
Fax: 303-648-5311
Email: inquire@globaleducationgroup.com
Web: www.globaleducationgroup.com

Credit Designation - Lab Professional, P.A.C.E.^®

The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.^®) Program will provide 1.0 contact hour of credit.

How to Obtain P.A.C.E.^® Credit

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.^® approved continuing education. To receive credit, the course must be completed before July 1, 2012.

Participants who have already received P.A.C.E.^® credit for attending the May 19th, 2010 live webcast are not eligible to receive additional credit for this enduring online activity.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive P.A.C.E.^® credit for viewing the webcast:

• Read all of the information above.
• View the complete webcast program.
• Click on the link to apply for P.A.C.E.^® credit.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
• After successful completion of this process, you will be redirected to the ASCLS CE Organizer where you may create and print an official ASCLS P.A.C.E.^® certificate based on your attendance and completion of this ASCLS-sponsored P.A.C.E.^® approved learning activity.

Should you have any P.A.C.E.^® questions regarding this activity, please contact:

ASCLS P.A.C.E.^®
2025 M Street NW, Suite 800
Washington DC 20036
Ph: 202-367-1174
Fx: 202-367-2174
http://www.ascls.org/

Release Date

Enduring Archive Release Date: July 1, 2010
Enduring Archive CME Expiration Date: July 1, 2011
Enduring Archive PACE Expiration Date: July 1, 2012

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Dane Garvin Ltd. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Policy on Privacy and Confidentiality

Global Education Group protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global Education Group and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Global Education Group and Dane Garvin, Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Medium Used

This program has been made available online.

“Update on Evolving Viral Hepatitis Therapy”

System Requirements

To view the this educational activity you will need a web broswer with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Cosponsor

    This activity is co-sponsored by the Association for Molecular Pathology.

Commercial Support Statement

    This activity is supported by an educational grant from Abbott Molecular.

Copyright

Copyright © July 1, 2010 - July 1, 2012.   Dane Garvin, Ltd. All Rights Reserved.   Permission for accreditation use granted to Global Education Group (GEG) and American Society for Clinical Laboratory Science (ASCLS).